Related Experiment Video
Updated: Jun 9, 2025

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Case-control study on risk factors for in-hospital mortality in patients with severe COVID-19
Kemei Wu1,2, Lili Yin2, Jiangqin Han1,2
1Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Insights
Advanced age, respiratory insufficiency, and elevated white blood cell (WBC) and creatine kinase (CK) levels are key risk factors for mortality in severe COVID-19 patients. These factors, along with decreased arterial oxygen partial pressure (PAO2), predict in-hospital death risk.
Area of Science:
- Infectious Diseases
- Critical Care Medicine
- Epidemiology
Background:
- Severe coronavirus disease 2019 (COVID-19) poses a significant threat to patient survival.
- Identifying independent risk factors and predictors of severe outcomes is crucial for effective patient management.
Purpose of the Study:
- To identify independent risk factors associated with patient mortality in severe COVID-19.
- To explore predictors that indicate the severity of COVID-19 cases.
Main Methods:
- A retrospective, observational, case-control study was conducted on adult patients with severe COVID-19.
- Univariate and multifactorial logistic regression analyses were used to examine demographic, comorbidity, and laboratory parameters.
Main Results:
- Deceased patients were older and had higher rates of respiratory insufficiency compared to survivors.
- Elevated white blood cell (WBC) count and creatine kinase (CK) levels, and decreased arterial oxygen partial pressure (PAO2) were significantly associated with mortality.
- Predictive values (AUC) for mortality were identified for age, respiratory insufficiency, highest WBC, highest CK, and first PAO2 values.
Conclusions:
- Advanced age, respiratory insufficiency, elevated WBC and CK, and decreased PAO2 are significant risk factors for mortality in severe COVID-19.
- Elevated WBC and CK levels demonstrate strong predictive value for in-hospital mortality risk.
Objective:
The purpose of this study was to identify independent risk factors affecting patient survival and explore predictors of severe cases of coronavirus disease 2019 (COVID-19).
Methods:
We conducted a retrospective, observational, case-control study on adult patients with severe COVID-19 who were admitted to affiliated hospitals in Tianjin between December 18, 2022, and January 31, 2023. We used univariate and multifactorial logistic regression analyses to analyze demographic indicators, comorbidity profiles, and laboratory parameters in two groups of patients (deceased and surviving) to identify independent risk factors for death in patients with severe COVID-19.
Results:
Patients in the deceased group were older than those in the survival group (p = 0.018), and there were more cases of coexisting respiratory insufficiency in the deceased group (p = 0.002). Additionally, laboratory test results for white blood cell count (WBC) and creatine kinase (CK) showed significantly higher values in the deceased group (p = 0.047 and p = 0.029, respectively), while arterial oxygen partial pressure (PAO2) showed significantly lower values compared to the survival group (p = 0.021). Age, respiratory insufficiency, WBCH (highest WBC value), CKH (highest CK value), and PAO2F (first PAO2 value) had area under curve (AUC) values of 0.698, 0.838, 0.721, 0.744, and 0.633, respectively.
Conclusion:
The main risk factors for mortality in patients with severe COVID-19 that we identified in this study were the advanced age of patients, coexisting respiratory insufficiency, elevated levels of WBC and CK, and decreased levels of PAO2. Elevated WBC and CK laboratory parameters, in particular, demonstrated good predictive value for in-hospital mortality risk.
More Related Videos
07:16An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient
Published on: November 30, 2022
10:38Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
Published on: January 16, 2019
Related Concept Videos
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Acute Coronary Syndrome IV: Interprofessional Care
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Acute Respiratory Failure-III